THE PHARMACIST'S NEWS SOURCE
Last Update: January 27, 2012
Email Register | Forgot Password
Password Remember me
       

Pertuzumab: Practice-changing for HER2+ MBC

January 2012

San Antonio—A new HER-targeted antibody, pertuzumab (Omnitarg, Roche), is poised to alter the treatment landscape of patients with HER2-positive metastatic breast cancer (MBC).
read more

  • Pertuzumab: Practice-changing for HER2+ MBC

    January 2012

    San Antonio—A new HER-targeted antibody, pertuzumab (Omnitarg, Roche), is poised to alter the treatment landscape of patients with HER2-positive metastatic breast cancer (MBC).
    read more

  • Zoledronic Acid Controversy in Breast Cancer Continues

    January 2012

    San Antonio—A growing body of evidence backs the contention that bisphosphonates can improve survival in breast cancer patients with low estrogen levels. The results of three studies of bisphosphonates in this setting ...
    read more

  • New AMA Policy Addresses Drug Shortages

    January 2012

    New Orleans—The American Medical Association’s (AMA) House of Delegates has introduced a policy backing existing measures to address what it is calling the “national public health emergency” of drug ...
    read more

The Most Read Articles From